vTv Therapeutics Inc. - (VTVT) Social Stream
vTv Therapeutics Inc (VTVT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering vTv Therapeutics Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 46 weeks, VTVT's average price target has gone down $1.75.
Over the past 51 weeks, VTVT's average upside potential has been 300.44%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VTVT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
VTVT's average broker recommendation rating improved by 0 over the prior 120 days.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VTVT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, vTv Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 492.85% of them.
- In terms of how vTv Therapeutics Inc fares relative to all US stocks, note that its number of analysts covering the stock is greater than 14.13% of that group.
- VTVT has a greater average analyst price target than 21.09% of all US stocks.
- vTv Therapeutics Inc's variance in analysts' estimates is lower than -34.1% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, VRPX, VIRI, and VCNX are the three stocks most similar to vTv Therapeutics Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding VTVT using the data that counts. Try POWR Ratings for free.